Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A 16-weeks, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Anti-inflammatory Actions of 320 mg Diovan in Patients With Type 2 Diabetes With and Without Coronary Artery Disease

NCT00982358 is registered in ClinicalTrials.gov with Charite University, Berlin, Germany as lead sponsor.

NCT NCT00982358
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00982358 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A 16-weeks, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Anti-inflammatory Actions of 320 mg Diovan in Patients With Type 2 Diabetes With and Without Coronary Artery Disease
Lead sponsor
Charite University, Berlin, Germany
Phase
Phase 4
Overall status
Completed
Start date
July 31, 2004
Completion date
March 31, 2007
Enrollment
121
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

coronary artery disease, hypertension, type 2 diabetes mellitus